医学
再生(生物学)
肝再生
肠道菌群
生物信息学
重症监护医学
生理学
细胞生物学
生物
免疫学
作者
Yana V. Kiseleva,Т. С. Жарикова,Roman Maslennikov,Shikhsaid M Temirbekov,A. V. Olsufieva,Olga L Polyakova,André Pontes‐Silva,Yu. O. Zharikov
标识
DOI:10.1016/j.jceh.2024.101455
摘要
Liver regeneration (LR) is a unique biological process with the ability to restore up to 70% of the organ. This allows for the preservation of liver resections for various liver tumors and for living donor liver transplantation (LDLT). However, in some cases, LR is insufficient and interventions that can improve LR are urgently needed. Gut microbiota (GM) is one of the factors influencing LR, as the liver and intestine are intimately connected through the gut-liver axis. Thus, healthy GM facilitates normal LR, whereas dysbiosis leads to impaired LR due to imbalance of bile acids, inflammatory cytokines, microbial metabolites, signaling pathways, etc. Therefore, GM can be considered as a new possible therapeutic target to improve LR. In this review, we critically observe the current knowledge about the influence of gut microbiota (GM) on liver regeneration (LR) and the possibility to improve this process, which may reduce complication and mortality rates after liver surgery. Although much research has been done on this topic, more clinical trials and systemic reviews are urgently needed to move this type of intervention from the experimental phase to the clinical field.
科研通智能强力驱动
Strongly Powered by AbleSci AI